Call us now 317.818.3100 or 888.404.6833
Raptiva was approved by the FDA in October, 2003 for the treatment of moderate to severe plaque psoriasis and is manufactured by Genentech.
The psoriasis drug Raptiva received a "black box" warning, the FDA's sternest warning, on October 16, 2008, about the risk of life-threatening infections including a rare brain infection and meningitis following the deaths of three patients using the psoriasis drug efalizumab, which is marketed as Raptiva. Further European regulators have recommended suspension of sales of Genentech Inc.'s psoriasis treatment Raptiva.
Patients taking Raptiva should watch for signs of serious infection. including confusion dizziness or loss of balance, difficulty talking or walking and vision problems, bruising, worsening of psoriasis or arthritis, sudden onset of numbness, tingling or weakness in the arms, legs, or face.
If you or a loved one has taken Raptiva (efalizumab) and suffered a life-threatening infection or death as a result of a side effect of Raptiva, you may have a legal claim.
For more information and for a free consultation, call Hovde Dassow & Deets at 1.888.404.6833 anytime (24 hours a day) or contact us online.
More in this section
or click here to contact us online
Hovde Dassow + Deets is proud to belong to—and be honored by—the following organizations. Please click a logo below to find out more.
Hovde Dassow + Deets is an Indianapolis-based law firm specializing in Personal Injury Law. Our attorneys practice in the following areas of personal injury law: Truck + car accidents, Medical malpractice, Drug liability, Wrongful death claims, Construction accidents, Nursing home injuries, Injuries to children, Pharmacy + prescription errors, ATV injuries, Defective product claims, Consumer class action, Aviation incidents, Train-crossing accidents. Hovde Dassow + Deets is based in Indianapolis, IN and serves clients and potential clients in the following areas and beyond: